In Search of Predictors of Switching Between Erythropoiesis-Stimulating Agents in Clinical Practice: A Multi-Regional Cohort Study

Background and objectives Switching between different erythropoiesis-stimulating agents (ESAs) during the first year of therapy is frequent (15–20%), much more so toward reference products than biosimilars. The objectives of this study were to investigate the frequency and identify the potential pre...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy biopharmaceuticals, and gene therapy, 2020-02, Vol.34 (1), p.55-64
Hauptverfasser:	Ingrasciotta, Ylenia, Belleudi, Valeria, Trotta, Francesco, Addis, Antonio, Fontana, Andrea, Chinellato, Alessandro, Ientile, Valentina, Tari, Daniele Ugo, Roberto, Giuseppe, Pastorello, Maurizio, Scondotto, Salvatore, Cananzi, Pasquale, Traversa, Giuseppe, Davoli, Marina, Rossi, Mariangela, Trifirò, Gianluca
Format:	Artikel
Sprache:	eng
Schlagworte:	Anemia Antibodies Biological products Biomedical and Life Sciences Biomedicine Cancer Research Cancer therapies Chemotherapy Chronic illnesses Cohort analysis Drugs Erythropoiesis Erythropoietin Expenditures FDA approval Hyperparathyroidism Iron Kidney diseases Molecular Medicine Original Research Article Patients Pharmacotherapy Studies Vitamin A
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!